On Rare Disease Day, we are dedicating this blog to Tommy, a selfless and caring individual we had the opportunity to serve for several years. In 2003,...
Rare Disease Day is an observance to help raise awareness for the 300 million people living with rare diseases worldwide. For Orsini, it is a day to...
Orsini Specialty Pharmacy, a leading independent specialty pharmacy focused on rare diseases and gene therapies, has earned URAC’s prestigious...
According to the National Institutes of Health (NIH), approximately 7,000 rare diseases affect between 25 and 30 million Americans (almost 1 in 10)1....
Almost 1 in 10 Americans are affected by a rare disease.1 Common challenges rare disease patients face include limited treatment options, little to no...
Tardive Dyskinesia (TD) is a neurological movement disorder typically characterized by repetitive, involuntary movements of the jaw, lips, and tongue....
Orsini Specialty Pharmacy, a leading independent specialty pharmacy focused on rare diseases and gene therapies, has been selected by Provention Bio,...
Mucopolysaccharidosis (MPS) is an inherited metabolic disease in which the body does not produce enough enzymes to break down sugars into simpler...
The National Association of Healthcare Quality (NAHQ) proudly established Healthcare Quality Week as a dedicated time to celebrate the profession and...
Dealing with a rare disease or complex condition can be exhausting, stressful, frustrating, costly, and at times, frightening. Even the most resilient...
Orsini is a leading independent national specialty pharmacy accredited by ACHC, JCAHO, URAC, and VIPPS. The services we provide allow patients, physicians, payors, and manufacturers to improve care, simplify processes, and achieve better outcomes.
Rare Disease Day: In Loving Memory of Tommy
Rare Disease Day: A Reminder of Our Immense Responsibility to Serve Patients and Families
Orsini Specialty Pharmacy Earns Rare Disease Pharmacy Center of Excellence Designation from URAC
From Diagnosis to Treatment: The Difficulties Rare Disease Patients Encounter
Payor Considerations When Evaluating a Specialty Pharmacy Partner